ClinicalTrials.gg
RecruitingNCT07641374Updated Nov 4, 2026

Auricular Acupuncture for Autonomic Balance and Pain in Fibromyalgia

An interventional study of The needles will be applied to specific auricular points: Point Zero, Shen Men, Thalamus, and Master Cerebral Point. in Fibromyalgia Syndrome, sponsored by Italian Association for the Research and the Scientific Update. Recruiting at 1 site in Italy. Open to female participants aged 35 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Italian Association for the Research and the Scientific Update · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Nov 4, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
35 Years to 64 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 41 studies in Fibromyalgia with a site in Italy — 16 open to participants now, 17 under way, none of them phase 3. Fibromyalgia · Italy.

Planned enrollment
23rd of 31
30 · median 80
Started
2026
with 5 others
No phase
21 of 41
12 open now
Primary completion
2026-12
later than 7 of 16 live
Registered
35th of 41
by date

Among the 41 studies in Fibromyalgia with a site in Italy, this one is the 23rd largest by planned enrollment of the 31 interventional ones that give a count, is one of 6 that started in 2026, is one of 21 with no phase, reaches primary completion later than 7 of the 16 other live ones, and was the 35th registered.

Fibromyalgia

1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

Browse Fibromyalgia studies →

Open to participants now

16 of the 41 studies in Fibromyalgia with a site in Italy are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 35 Years to 64 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 41 studies in Fibromyalgia with a site in Italy, or all of them as a file.
02

Study summary

This longitudinal study evaluates the effects of semi-permanent auricular acupuncture on the Autonomic Nervous System (ANS) activity and pressure pain threshold in adult female patients (aged 35-64) diagnosed with Fibromyalgia according to the 2016 American College of Rheumatology (ACR) criteria. The study aims to investigate how a 5-week treatment cycle influences cardiac autonomic regulation and pain sensitivity

Read the detailed description

Participants will undergo a series of 5 weekly sessions of auricular acupuncture using semi-permanent needles (Pyonex Seirin 0.9 mm). The needles will be applied to specific auricular points: Point Zero, Shen Men, Thalamus, and Master Cerebral Point. Each application will last for 72 hours, with the patient performing the removal

03

Conditions studied

  • Fibromyalgia Syndrome

Browse trials for

Keywords

  • Ear acupuncture
  • Heart Rate Variability (HRV)
  • pressure pain threshold
  • Fibromyalgia
04

Who can participate

Ages eligible
35 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Confirmed diagnosis of Fibromyalgia by a Rheumatologist according to the 2016 ACR (American College of Rheumatology) criteria.

  • Female sex.
  • Aged between 35 and 64 years.
  • Signed written .

Exclusion criteria

Exclusion Criteria:

  • Presence of cardiac rhythm disorders such as permanent Atrial Fibrillation.
  • Patients with Pacemakers.
  • Subjects affected by (COPD)
  • Patients taking continuous medications that can alter the autonomic response (e.g., beta-blockers, antiarrhythmics, inhaled beta2-agonists).
  • Subjects with specific to auricular acupuncture.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Auricular Acupuncture for Autonomic Balance and Pain in Fibromyalgia.

    Participants will undergo a series of 5 weekly sessions of auricular acupuncture using semi-permanent needles (Pyonex Seirin 0.9 mm). The needles will be applied to specific auricular points: Point Zero, Shen Men, Thalamus, and Master Cerebral Point. Each application will last for 72 hours, with the patient performing the removal

    Device: The needles will be applied to specific auricular points: Point Zero, Shen Men, Thalamus, and Master Cerebral Point.

Interventions

  • DeviceThe needles will be applied to specific auricular points: Point Zero, Shen Men, Thalamus, and Master Cerebral Point.

    Participants will undergo a series of 5 weekly sessions of auricular acupuncture using semi-permanent needles (Pyonex Seirin 0.9 mm). The needles will be applied to specific auricular points: Point Zero, Shen Men, Thalamus, and Master Cerebral Point. Each application will last for 72 hours, with the patient performing the removal

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Autonomic Nervous System (ANS) Balance via LF/HF Ratio

    Evaluated through Photoplethysmography (PPG) using the PPG Stress Flow device. The autonomic nervous system balance is expressed specifically by the Low Frequency to High Frequency (LF/HF) ratio. Other spectral parameters (SDNN and HF power) are collected simultaneously to support the comprehensive Heart Rate Variability (HRV) analysis. All measurements are taken immediately before each acupuncture session.

    Time frame: Baseline (T0), Week 1 (T1), Week 2 (T2), Week 3 (T3), Week 4 (T4), and Follow-up at Week 8 (T5).

Secondary outcomes

  1. Change from baseline in Pressure Pain Threshold (PPT)

    Measured using the Force Ten FPX 25 Algometer to determine the minimum pressure perceived as painful. Measurements are taken at three specific body points: Trapezius (GB21), Lateral Epicondyle (LI11), and below the knee (ST36). Measurements are taken immediately before the acupuncture session

    Time frame: Baseline (T0), Week 2 (T2), Week 4 (T4), and Week 8 (T5)

07

Study locations

1 of 1 sites recruiting
  • Pain Therapy Clinic, Lonigo (VI)
    Lonigo, VICENZA 36045, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 3 months after the start.

Of 439 non-industry interventional studies with no phase under Fibromyalgia, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 3 months is below that.

Counting every sponsor, half of 452 studies reached it within 15 months; a quarter within 6 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: start Jun 2026 → Sep 2026, primary completion Aug 2026 → Dec 2026 and completion Aug 2026 → Mar 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2026
First posted
Jun 11, 2026
StartActual
Sep 1, 2026was Jun 2026
Primary completionEst.
Dec 31, 2026was Aug 2026
CompletionEst.
Mar 31, 2027was Aug 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
Pain Therapy Clinic, Lonigo (VI) is now Recruiting
Nov 4, 2026
Start date
Jun 1, 2026→Sep 1, 2026 (actual)
Nov 4, 2026
Primary completion
Aug 31, 2026→Dec 31, 2026
Nov 4, 2026
Study completion
Aug 31, 2026→Mar 31, 2027
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Recruiting
    Pain Therapy Clinic, Lonigo (VI) is now Recruiting
    Start date Jun 1, 2026→Sep 1, 2026 (now actual)
    Primary completion Aug 31, 2026→Dec 31, 2026
    Study completion Aug 31, 2026→Mar 31, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07641374
Lead sponsor
Italian Association for the Research and the Scientific Update
Responsible party
Antonello Lovato (Medical Doctor and Research Coordinator, Italian Association for the Research and the Scientific Update) — Principal investigator
First posted
Jun 11, 2026
Start date
Sep 1, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Antonello Lovato, MD
Contact
lovatoantonello@gmail.com
+00390444832740

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion